These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 9655536
1. Erythromycin resistance of Streptococcus pyogenes in Madrid. Orden B, Perez-Trallero E, Montes M, Martínez R. Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536 [Abstract] [Full Text] [Related]
8. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Hsueh PR, Teng LJ, Lee CM, Huang WK, Wu TL, Wan JH, Yang D, Shyr JM, Chuang YC, Yan JJ, Lu JJ, Wu JJ, Ko WC, Chang FY, Yang YC, Lau YJ, Liu YC, Leu HS, Liu CY, Luh KT, SMART Program 2001 Data. Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461 [Abstract] [Full Text] [Related]
11. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting. Alós JI, Aracil B, Oteo J, Torres C, Gómez-Garcés JL. J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081 [Abstract] [Full Text] [Related]
13. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, Loukil C, Brahimi N, Le Thomas I, Deforche D. Antimicrob Agents Chemother; 2000 Jun; 44(6):1453-7. PubMed ID: 10817692 [Abstract] [Full Text] [Related]
14. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Liu X, Shen X, Chang H, Huang G, Fu Z, Zheng Y, Wang L, Li C, Liu L, Shen Y, Yang Y. Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846 [Abstract] [Full Text] [Related]
16. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, Ieven M, Goossens H. J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498 [Abstract] [Full Text] [Related]
17. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. Alós JI, Aracil B, Oteo J, Gómez-Garcés JL, Spanish Group for the Study of Infection in the Primary Health Care Setting (IAP-SEIMC). J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699 [Abstract] [Full Text] [Related]
18. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia. Ksia S, Smaoui H, Hraoui M, Bouafsoun A, Boutiba-Ben Boubaker I, Kechrid A. Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848 [Abstract] [Full Text] [Related]
19. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Reinert RR, Lütticken R, Bryskier A, Al-Lahham A. Antimicrob Agents Chemother; 2003 Feb; 47(2):489-93. PubMed ID: 12543648 [Abstract] [Full Text] [Related]
20. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. Melo-Cristino J, Fernandes ML. Microb Drug Resist; 1999 Feb; 5(3):219-25. PubMed ID: 10566873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]